Haoxi Health Technology Limited (HAO)
(Real Time Quote from BATS)
$6.50 USD
+0.11 (1.72%)
Updated May 22, 2024 12:31 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HAO 6.50 +0.11(1.72%)
Will HAO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for HAO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for HAO
12 Communication Services Stocks Moving In Monday's After-Market Session
Haoxi Health Tech Forges Major 2024 Biotech Partnership
Haoxi Health Technology Limited Enters into Rebate Agreement with Clients on Advertising Placement Campaign
Haoxi Health Technology enters into rebate agreement with Jinan Yanling
DGLY, KUKE among major communication services gainers; DRCT, FNGR among losers